nodes	percent_of_prediction	percent_of_DWPC	metapath
Dimenhydrinate—Neuropathy peripheral—Epirubicin—hematologic cancer	0.000378	0.000388	CcSEcCtD
Dimenhydrinate—Vomiting—Thalidomide—hematologic cancer	0.000375	0.000386	CcSEcCtD
Dimenhydrinate—Dizziness—Carmustine—hematologic cancer	0.000375	0.000386	CcSEcCtD
Dimenhydrinate—Constipation—Etoposide—hematologic cancer	0.000375	0.000386	CcSEcCtD
Dimenhydrinate—Dysuria—Doxorubicin—hematologic cancer	0.000374	0.000384	CcSEcCtD
Dimenhydrinate—Rash—Thalidomide—hematologic cancer	0.000372	0.000383	CcSEcCtD
Dimenhydrinate—Dermatitis—Thalidomide—hematologic cancer	0.000372	0.000382	CcSEcCtD
Dimenhydrinate—Dizziness—Alitretinoin—hematologic cancer	0.000371	0.000382	CcSEcCtD
Dimenhydrinate—Diarrhoea—Vincristine—hematologic cancer	0.00037	0.000381	CcSEcCtD
Dimenhydrinate—Headache—Thalidomide—hematologic cancer	0.00037	0.00038	CcSEcCtD
Dimenhydrinate—Pollakiuria—Doxorubicin—hematologic cancer	0.000369	0.00038	CcSEcCtD
Dimenhydrinate—Asthenia—Gemcitabine—hematologic cancer	0.000368	0.000379	CcSEcCtD
Dimenhydrinate—Dizziness—Ifosfamide—hematologic cancer	0.000367	0.000377	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Doxorubicin—hematologic cancer	0.000365	0.000375	CcSEcCtD
Dimenhydrinate—Vision blurred—Prednisone—hematologic cancer	0.000363	0.000373	CcSEcCtD
Dimenhydrinate—Nausea—Thiotepa—hematologic cancer	0.000363	0.000373	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Etoposide—hematologic cancer	0.000361	0.000372	CcSEcCtD
Dimenhydrinate—Diarrhoea—Mitoxantrone—hematologic cancer	0.000361	0.000371	CcSEcCtD
Dimenhydrinate—Diarrhoea—Irinotecan—hematologic cancer	0.000361	0.000371	CcSEcCtD
Dimenhydrinate—Vomiting—Carmustine—hematologic cancer	0.00036	0.000371	CcSEcCtD
Dimenhydrinate—Insomnia—Triamcinolone—hematologic cancer	0.00036	0.00037	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Epirubicin—hematologic cancer	0.00036	0.00037	CcSEcCtD
Dimenhydrinate—Dizziness—Vincristine—hematologic cancer	0.000358	0.000368	CcSEcCtD
Dimenhydrinate—Rash—Carmustine—hematologic cancer	0.000357	0.000368	CcSEcCtD
Dimenhydrinate—Dermatitis—Carmustine—hematologic cancer	0.000357	0.000367	CcSEcCtD
Dimenhydrinate—Vomiting—Alitretinoin—hematologic cancer	0.000357	0.000367	CcSEcCtD
Dimenhydrinate—Paraesthesia—Triamcinolone—hematologic cancer	0.000357	0.000367	CcSEcCtD
Dimenhydrinate—Drowsiness—Doxorubicin—hematologic cancer	0.000357	0.000367	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Prednisolone—hematologic cancer	0.000356	0.000366	CcSEcCtD
Dimenhydrinate—Headache—Carmustine—hematologic cancer	0.000355	0.000365	CcSEcCtD
Dimenhydrinate—Rash—Alitretinoin—hematologic cancer	0.000354	0.000364	CcSEcCtD
Dimenhydrinate—Agitation—Prednisone—hematologic cancer	0.000354	0.000364	CcSEcCtD
Dimenhydrinate—Dermatitis—Alitretinoin—hematologic cancer	0.000354	0.000364	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Betamethasone—hematologic cancer	0.000353	0.000363	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Dexamethasone—hematologic cancer	0.000353	0.000363	CcSEcCtD
Dimenhydrinate—Vomiting—Ifosfamide—hematologic cancer	0.000353	0.000363	CcSEcCtD
Dimenhydrinate—Tachycardia—Dexamethasone—hematologic cancer	0.000352	0.000362	CcSEcCtD
Dimenhydrinate—Tachycardia—Betamethasone—hematologic cancer	0.000352	0.000362	CcSEcCtD
Dimenhydrinate—Headache—Alitretinoin—hematologic cancer	0.000352	0.000362	CcSEcCtD
Dimenhydrinate—Diarrhoea—Gemcitabine—hematologic cancer	0.000351	0.000361	CcSEcCtD
Dimenhydrinate—Nausea—Thalidomide—hematologic cancer	0.000351	0.000361	CcSEcCtD
Dimenhydrinate—Dyspepsia—Triamcinolone—hematologic cancer	0.00035	0.00036	CcSEcCtD
Dimenhydrinate—Rash—Ifosfamide—hematologic cancer	0.00035	0.00036	CcSEcCtD
Dimenhydrinate—Dermatitis—Ifosfamide—hematologic cancer	0.00035	0.00036	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Doxorubicin—hematologic cancer	0.000349	0.000359	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Dexamethasone—hematologic cancer	0.000349	0.000359	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Betamethasone—hematologic cancer	0.000349	0.000359	CcSEcCtD
Dimenhydrinate—Dizziness—Irinotecan—hematologic cancer	0.000349	0.000358	CcSEcCtD
Dimenhydrinate—Urticaria—Etoposide—hematologic cancer	0.000348	0.000358	CcSEcCtD
Dimenhydrinate—Vertigo—Prednisone—hematologic cancer	0.000346	0.000356	CcSEcCtD
Dimenhydrinate—Tinnitus—Methotrexate—hematologic cancer	0.000345	0.000354	CcSEcCtD
Dimenhydrinate—Vomiting—Vincristine—hematologic cancer	0.000344	0.000354	CcSEcCtD
Dimenhydrinate—Anorexia—Betamethasone—hematologic cancer	0.000344	0.000354	CcSEcCtD
Dimenhydrinate—Anorexia—Dexamethasone—hematologic cancer	0.000344	0.000354	CcSEcCtD
Dimenhydrinate—Urticaria—Prednisolone—hematologic cancer	0.000344	0.000353	CcSEcCtD
Dimenhydrinate—Asthenia—Cisplatin—hematologic cancer	0.000343	0.000353	CcSEcCtD
Dimenhydrinate—Fatigue—Triamcinolone—hematologic cancer	0.000343	0.000353	CcSEcCtD
Dimenhydrinate—Rash—Vincristine—hematologic cancer	0.000341	0.000351	CcSEcCtD
Dimenhydrinate—Dermatitis—Vincristine—hematologic cancer	0.000341	0.000351	CcSEcCtD
Dimenhydrinate—Headache—Vincristine—hematologic cancer	0.000339	0.000349	CcSEcCtD
Dimenhydrinate—Hypotension—Betamethasone—hematologic cancer	0.000337	0.000347	CcSEcCtD
Dimenhydrinate—Hypotension—Dexamethasone—hematologic cancer	0.000337	0.000347	CcSEcCtD
Dimenhydrinate—Nausea—Carmustine—hematologic cancer	0.000337	0.000346	CcSEcCtD
Dimenhydrinate—Vomiting—Irinotecan—hematologic cancer	0.000335	0.000345	CcSEcCtD
Dimenhydrinate—Vomiting—Mitoxantrone—hematologic cancer	0.000335	0.000345	CcSEcCtD
Dimenhydrinate—Nausea—Alitretinoin—hematologic cancer	0.000334	0.000343	CcSEcCtD
Dimenhydrinate—Convulsion—Prednisone—hematologic cancer	0.000334	0.000343	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Doxorubicin—hematologic cancer	0.000333	0.000342	CcSEcCtD
Dimenhydrinate—Rash—Mitoxantrone—hematologic cancer	0.000332	0.000342	CcSEcCtD
Dimenhydrinate—Rash—Irinotecan—hematologic cancer	0.000332	0.000342	CcSEcCtD
Dimenhydrinate—Dermatitis—Irinotecan—hematologic cancer	0.000332	0.000341	CcSEcCtD
Dimenhydrinate—Dermatitis—Mitoxantrone—hematologic cancer	0.000332	0.000341	CcSEcCtD
Dimenhydrinate—Chills—Methotrexate—hematologic cancer	0.000332	0.000341	CcSEcCtD
Dimenhydrinate—Headache—Irinotecan—hematologic cancer	0.00033	0.00034	CcSEcCtD
Dimenhydrinate—Headache—Mitoxantrone—hematologic cancer	0.00033	0.00034	CcSEcCtD
Dimenhydrinate—Nausea—Ifosfamide—hematologic cancer	0.00033	0.000339	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Triamcinolone—hematologic cancer	0.000328	0.000337	CcSEcCtD
Dimenhydrinate—Diarrhoea—Cisplatin—hematologic cancer	0.000327	0.000337	CcSEcCtD
Dimenhydrinate—Vomiting—Gemcitabine—hematologic cancer	0.000326	0.000336	CcSEcCtD
Dimenhydrinate—Insomnia—Betamethasone—hematologic cancer	0.000326	0.000336	CcSEcCtD
Dimenhydrinate—Insomnia—Dexamethasone—hematologic cancer	0.000326	0.000336	CcSEcCtD
Dimenhydrinate—Paraesthesia—Betamethasone—hematologic cancer	0.000324	0.000333	CcSEcCtD
Dimenhydrinate—Paraesthesia—Dexamethasone—hematologic cancer	0.000324	0.000333	CcSEcCtD
Dimenhydrinate—Rash—Gemcitabine—hematologic cancer	0.000324	0.000333	CcSEcCtD
Dimenhydrinate—Dermatitis—Gemcitabine—hematologic cancer	0.000323	0.000333	CcSEcCtD
Dimenhydrinate—Tinnitus—Epirubicin—hematologic cancer	0.000323	0.000332	CcSEcCtD
Dimenhydrinate—Headache—Gemcitabine—hematologic cancer	0.000322	0.000331	CcSEcCtD
Dimenhydrinate—Nausea—Vincristine—hematologic cancer	0.000321	0.000331	CcSEcCtD
Dimenhydrinate—Dyspepsia—Dexamethasone—hematologic cancer	0.000318	0.000327	CcSEcCtD
Dimenhydrinate—Dyspepsia—Betamethasone—hematologic cancer	0.000318	0.000327	CcSEcCtD
Dimenhydrinate—Urticaria—Triamcinolone—hematologic cancer	0.000316	0.000325	CcSEcCtD
Dimenhydrinate—Asthenia—Etoposide—hematologic cancer	0.000315	0.000323	CcSEcCtD
Dimenhydrinate—Decreased appetite—Betamethasone—hematologic cancer	0.000314	0.000323	CcSEcCtD
Dimenhydrinate—Decreased appetite—Dexamethasone—hematologic cancer	0.000314	0.000323	CcSEcCtD
Dimenhydrinate—Nausea—Mitoxantrone—hematologic cancer	0.000313	0.000322	CcSEcCtD
Dimenhydrinate—Nausea—Irinotecan—hematologic cancer	0.000313	0.000322	CcSEcCtD
Dimenhydrinate—Fatigue—Dexamethasone—hematologic cancer	0.000311	0.00032	CcSEcCtD
Dimenhydrinate—Fatigue—Betamethasone—hematologic cancer	0.000311	0.00032	CcSEcCtD
Dimenhydrinate—Chills—Epirubicin—hematologic cancer	0.00031	0.000319	CcSEcCtD
Dimenhydrinate—Tachycardia—Prednisone—hematologic cancer	0.000307	0.000315	CcSEcCtD
Dimenhydrinate—Nausea—Gemcitabine—hematologic cancer	0.000305	0.000314	CcSEcCtD
Dimenhydrinate—Vomiting—Cisplatin—hematologic cancer	0.000304	0.000313	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Prednisone—hematologic cancer	0.000304	0.000312	CcSEcCtD
Dimenhydrinate—Vision blurred—Methotrexate—hematologic cancer	0.000303	0.000312	CcSEcCtD
Dimenhydrinate—Rash—Cisplatin—hematologic cancer	0.000302	0.00031	CcSEcCtD
Dimenhydrinate—Dermatitis—Cisplatin—hematologic cancer	0.000301	0.00031	CcSEcCtD
Dimenhydrinate—Diarrhoea—Etoposide—hematologic cancer	0.0003	0.000308	CcSEcCtD
Dimenhydrinate—Anorexia—Prednisone—hematologic cancer	0.0003	0.000308	CcSEcCtD
Dimenhydrinate—Tinnitus—Doxorubicin—hematologic cancer	0.000298	0.000307	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Dexamethasone—hematologic cancer	0.000297	0.000306	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Betamethasone—hematologic cancer	0.000297	0.000306	CcSEcCtD
Dimenhydrinate—Tension—Epirubicin—hematologic cancer	0.000295	0.000304	CcSEcCtD
Dimenhydrinate—Nervousness—Epirubicin—hematologic cancer	0.000292	0.000301	CcSEcCtD
Dimenhydrinate—Dizziness—Etoposide—hematologic cancer	0.00029	0.000298	CcSEcCtD
Dimenhydrinate—Vertigo—Methotrexate—hematologic cancer	0.000289	0.000297	CcSEcCtD
Dimenhydrinate—Chills—Doxorubicin—hematologic cancer	0.000287	0.000295	CcSEcCtD
Dimenhydrinate—Urticaria—Dexamethasone—hematologic cancer	0.000287	0.000295	CcSEcCtD
Dimenhydrinate—Urticaria—Betamethasone—hematologic cancer	0.000287	0.000295	CcSEcCtD
Dimenhydrinate—Dizziness—Prednisolone—hematologic cancer	0.000286	0.000294	CcSEcCtD
Dimenhydrinate—Asthenia—Triamcinolone—hematologic cancer	0.000285	0.000293	CcSEcCtD
Dimenhydrinate—Nausea—Cisplatin—hematologic cancer	0.000284	0.000292	CcSEcCtD
Dimenhydrinate—Insomnia—Prednisone—hematologic cancer	0.000284	0.000292	CcSEcCtD
Dimenhydrinate—Vision blurred—Epirubicin—hematologic cancer	0.000284	0.000292	CcSEcCtD
Dimenhydrinate—Paraesthesia—Prednisone—hematologic cancer	0.000282	0.00029	CcSEcCtD
Dimenhydrinate—Convulsion—Methotrexate—hematologic cancer	0.000279	0.000287	CcSEcCtD
Dimenhydrinate—Vomiting—Etoposide—hematologic cancer	0.000279	0.000287	CcSEcCtD
Dimenhydrinate—Agitation—Epirubicin—hematologic cancer	0.000277	0.000285	CcSEcCtD
Dimenhydrinate—Dyspepsia—Prednisone—hematologic cancer	0.000277	0.000284	CcSEcCtD
Dimenhydrinate—Rash—Etoposide—hematologic cancer	0.000276	0.000284	CcSEcCtD
Dimenhydrinate—Dermatitis—Etoposide—hematologic cancer	0.000276	0.000284	CcSEcCtD
Dimenhydrinate—Headache—Etoposide—hematologic cancer	0.000275	0.000282	CcSEcCtD
Dimenhydrinate—Tension—Doxorubicin—hematologic cancer	0.000273	0.000281	CcSEcCtD
Dimenhydrinate—Decreased appetite—Prednisone—hematologic cancer	0.000273	0.000281	CcSEcCtD
Dimenhydrinate—Rash—Prednisolone—hematologic cancer	0.000273	0.00028	CcSEcCtD
Dimenhydrinate—Dermatitis—Prednisolone—hematologic cancer	0.000272	0.00028	CcSEcCtD
Dimenhydrinate—Fatigue—Prednisone—hematologic cancer	0.000271	0.000279	CcSEcCtD
Dimenhydrinate—Headache—Prednisolone—hematologic cancer	0.000271	0.000279	CcSEcCtD
Dimenhydrinate—Nervousness—Doxorubicin—hematologic cancer	0.000271	0.000278	CcSEcCtD
Dimenhydrinate—Vertigo—Epirubicin—hematologic cancer	0.000271	0.000278	CcSEcCtD
Dimenhydrinate—Constipation—Prednisone—hematologic cancer	0.000269	0.000276	CcSEcCtD
Dimenhydrinate—Palpitations—Epirubicin—hematologic cancer	0.000266	0.000274	CcSEcCtD
Dimenhydrinate—Confusional state—Methotrexate—hematologic cancer	0.000265	0.000272	CcSEcCtD
Dimenhydrinate—Dizziness—Triamcinolone—hematologic cancer	0.000263	0.00027	CcSEcCtD
Dimenhydrinate—Vision blurred—Doxorubicin—hematologic cancer	0.000263	0.00027	CcSEcCtD
Dimenhydrinate—Convulsion—Epirubicin—hematologic cancer	0.000261	0.000268	CcSEcCtD
Dimenhydrinate—Nausea—Etoposide—hematologic cancer	0.00026	0.000268	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Prednisone—hematologic cancer	0.000259	0.000266	CcSEcCtD
Dimenhydrinate—Asthenia—Dexamethasone—hematologic cancer	0.000259	0.000266	CcSEcCtD
Dimenhydrinate—Asthenia—Betamethasone—hematologic cancer	0.000259	0.000266	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Methotrexate—hematologic cancer	0.000257	0.000264	CcSEcCtD
Dimenhydrinate—Nausea—Prednisolone—hematologic cancer	0.000257	0.000264	CcSEcCtD
Dimenhydrinate—Agitation—Doxorubicin—hematologic cancer	0.000256	0.000263	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Methotrexate—hematologic cancer	0.000254	0.000261	CcSEcCtD
Dimenhydrinate—Vomiting—Triamcinolone—hematologic cancer	0.000253	0.00026	CcSEcCtD
Dimenhydrinate—Rash—Triamcinolone—hematologic cancer	0.000251	0.000258	CcSEcCtD
Dimenhydrinate—Dry mouth—Epirubicin—hematologic cancer	0.000251	0.000258	CcSEcCtD
Dimenhydrinate—Dermatitis—Triamcinolone—hematologic cancer	0.000251	0.000258	CcSEcCtD
Dimenhydrinate—Vertigo—Doxorubicin—hematologic cancer	0.00025	0.000257	CcSEcCtD
Dimenhydrinate—Anorexia—Methotrexate—hematologic cancer	0.00025	0.000257	CcSEcCtD
Dimenhydrinate—Urticaria—Prednisone—hematologic cancer	0.00025	0.000257	CcSEcCtD
Dimenhydrinate—Headache—Triamcinolone—hematologic cancer	0.000249	0.000256	CcSEcCtD
Dimenhydrinate—Confusional state—Epirubicin—hematologic cancer	0.000248	0.000255	CcSEcCtD
Dimenhydrinate—Diarrhoea—Dexamethasone—hematologic cancer	0.000247	0.000254	CcSEcCtD
Dimenhydrinate—Diarrhoea—Betamethasone—hematologic cancer	0.000247	0.000254	CcSEcCtD
Dimenhydrinate—Palpitations—Doxorubicin—hematologic cancer	0.000246	0.000253	CcSEcCtD
Dimenhydrinate—Hypotension—Methotrexate—hematologic cancer	0.000245	0.000252	CcSEcCtD
Dimenhydrinate—Convulsion—Doxorubicin—hematologic cancer	0.000241	0.000248	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Epirubicin—hematologic cancer	0.000241	0.000247	CcSEcCtD
Dimenhydrinate—Tachycardia—Epirubicin—hematologic cancer	0.00024	0.000247	CcSEcCtD
Dimenhydrinate—Dizziness—Betamethasone—hematologic cancer	0.000239	0.000245	CcSEcCtD
Dimenhydrinate—Dizziness—Dexamethasone—hematologic cancer	0.000239	0.000245	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Epirubicin—hematologic cancer	0.000238	0.000244	CcSEcCtD
Dimenhydrinate—Insomnia—Methotrexate—hematologic cancer	0.000238	0.000244	CcSEcCtD
Dimenhydrinate—Nausea—Triamcinolone—hematologic cancer	0.000236	0.000243	CcSEcCtD
Dimenhydrinate—Paraesthesia—Methotrexate—hematologic cancer	0.000236	0.000242	CcSEcCtD
Dimenhydrinate—Anorexia—Epirubicin—hematologic cancer	0.000234	0.000241	CcSEcCtD
Dimenhydrinate—Somnolence—Methotrexate—hematologic cancer	0.000233	0.00024	CcSEcCtD
Dimenhydrinate—Dry mouth—Doxorubicin—hematologic cancer	0.000232	0.000239	CcSEcCtD
Dimenhydrinate—Dyspepsia—Methotrexate—hematologic cancer	0.000231	0.000238	CcSEcCtD
Dimenhydrinate—Hypotension—Epirubicin—hematologic cancer	0.00023	0.000236	CcSEcCtD
Dimenhydrinate—Vomiting—Dexamethasone—hematologic cancer	0.000229	0.000236	CcSEcCtD
Dimenhydrinate—Vomiting—Betamethasone—hematologic cancer	0.000229	0.000236	CcSEcCtD
Dimenhydrinate—Confusional state—Doxorubicin—hematologic cancer	0.000229	0.000236	CcSEcCtD
Dimenhydrinate—Decreased appetite—Methotrexate—hematologic cancer	0.000228	0.000235	CcSEcCtD
Dimenhydrinate—Rash—Dexamethasone—hematologic cancer	0.000228	0.000234	CcSEcCtD
Dimenhydrinate—Rash—Betamethasone—hematologic cancer	0.000228	0.000234	CcSEcCtD
Dimenhydrinate—Dermatitis—Dexamethasone—hematologic cancer	0.000227	0.000234	CcSEcCtD
Dimenhydrinate—Dermatitis—Betamethasone—hematologic cancer	0.000227	0.000234	CcSEcCtD
Dimenhydrinate—Fatigue—Methotrexate—hematologic cancer	0.000226	0.000233	CcSEcCtD
Dimenhydrinate—Headache—Dexamethasone—hematologic cancer	0.000226	0.000232	CcSEcCtD
Dimenhydrinate—Headache—Betamethasone—hematologic cancer	0.000226	0.000232	CcSEcCtD
Dimenhydrinate—Asthenia—Prednisone—hematologic cancer	0.000225	0.000232	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Doxorubicin—hematologic cancer	0.000223	0.000229	CcSEcCtD
Dimenhydrinate—Insomnia—Epirubicin—hematologic cancer	0.000222	0.000229	CcSEcCtD
Dimenhydrinate—Tachycardia—Doxorubicin—hematologic cancer	0.000222	0.000228	CcSEcCtD
Dimenhydrinate—Paraesthesia—Epirubicin—hematologic cancer	0.000221	0.000227	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Doxorubicin—hematologic cancer	0.00022	0.000226	CcSEcCtD
Dimenhydrinate—Somnolence—Epirubicin—hematologic cancer	0.000218	0.000225	CcSEcCtD
Dimenhydrinate—Anorexia—Doxorubicin—hematologic cancer	0.000217	0.000223	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Methotrexate—hematologic cancer	0.000216	0.000223	CcSEcCtD
Dimenhydrinate—Dyspepsia—Epirubicin—hematologic cancer	0.000216	0.000222	CcSEcCtD
Dimenhydrinate—Diarrhoea—Prednisone—hematologic cancer	0.000215	0.000221	CcSEcCtD
Dimenhydrinate—Nausea—Dexamethasone—hematologic cancer	0.000214	0.00022	CcSEcCtD
Dimenhydrinate—Nausea—Betamethasone—hematologic cancer	0.000214	0.00022	CcSEcCtD
Dimenhydrinate—Decreased appetite—Epirubicin—hematologic cancer	0.000214	0.00022	CcSEcCtD
Dimenhydrinate—Hypotension—Doxorubicin—hematologic cancer	0.000212	0.000218	CcSEcCtD
Dimenhydrinate—Fatigue—Epirubicin—hematologic cancer	0.000212	0.000218	CcSEcCtD
Dimenhydrinate—Constipation—Epirubicin—hematologic cancer	0.00021	0.000216	CcSEcCtD
Dimenhydrinate—Urticaria—Methotrexate—hematologic cancer	0.000209	0.000215	CcSEcCtD
Dimenhydrinate—Dizziness—Prednisone—hematologic cancer	0.000208	0.000214	CcSEcCtD
Dimenhydrinate—Insomnia—Doxorubicin—hematologic cancer	0.000206	0.000211	CcSEcCtD
Dimenhydrinate—Paraesthesia—Doxorubicin—hematologic cancer	0.000204	0.00021	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Epirubicin—hematologic cancer	0.000203	0.000208	CcSEcCtD
Dimenhydrinate—Somnolence—Doxorubicin—hematologic cancer	0.000202	0.000208	CcSEcCtD
Dimenhydrinate—Dyspepsia—Doxorubicin—hematologic cancer	0.0002	0.000206	CcSEcCtD
Dimenhydrinate—Vomiting—Prednisone—hematologic cancer	0.0002	0.000205	CcSEcCtD
Dimenhydrinate—Rash—Prednisone—hematologic cancer	0.000198	0.000204	CcSEcCtD
Dimenhydrinate—Dermatitis—Prednisone—hematologic cancer	0.000198	0.000204	CcSEcCtD
Dimenhydrinate—Decreased appetite—Doxorubicin—hematologic cancer	0.000198	0.000203	CcSEcCtD
Dimenhydrinate—Headache—Prednisone—hematologic cancer	0.000197	0.000202	CcSEcCtD
Dimenhydrinate—Fatigue—Doxorubicin—hematologic cancer	0.000196	0.000202	CcSEcCtD
Dimenhydrinate—Urticaria—Epirubicin—hematologic cancer	0.000195	0.000201	CcSEcCtD
Dimenhydrinate—Constipation—Doxorubicin—hematologic cancer	0.000194	0.0002	CcSEcCtD
Dimenhydrinate—Asthenia—Methotrexate—hematologic cancer	0.000188	0.000194	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Doxorubicin—hematologic cancer	0.000187	0.000193	CcSEcCtD
Dimenhydrinate—Nausea—Prednisone—hematologic cancer	0.000187	0.000192	CcSEcCtD
Dimenhydrinate—Urticaria—Doxorubicin—hematologic cancer	0.000181	0.000186	CcSEcCtD
Dimenhydrinate—Diarrhoea—Methotrexate—hematologic cancer	0.00018	0.000185	CcSEcCtD
Dimenhydrinate—Asthenia—Epirubicin—hematologic cancer	0.000176	0.000181	CcSEcCtD
Dimenhydrinate—Dizziness—Methotrexate—hematologic cancer	0.000174	0.000179	CcSEcCtD
Dimenhydrinate—Diarrhoea—Epirubicin—hematologic cancer	0.000168	0.000173	CcSEcCtD
Dimenhydrinate—Vomiting—Methotrexate—hematologic cancer	0.000167	0.000172	CcSEcCtD
Dimenhydrinate—Rash—Methotrexate—hematologic cancer	0.000166	0.00017	CcSEcCtD
Dimenhydrinate—Dermatitis—Methotrexate—hematologic cancer	0.000165	0.00017	CcSEcCtD
Dimenhydrinate—Headache—Methotrexate—hematologic cancer	0.000165	0.000169	CcSEcCtD
Dimenhydrinate—Asthenia—Doxorubicin—hematologic cancer	0.000163	0.000168	CcSEcCtD
Dimenhydrinate—Dizziness—Epirubicin—hematologic cancer	0.000163	0.000167	CcSEcCtD
Dimenhydrinate—Vomiting—Epirubicin—hematologic cancer	0.000156	0.000161	CcSEcCtD
Dimenhydrinate—Nausea—Methotrexate—hematologic cancer	0.000156	0.00016	CcSEcCtD
Dimenhydrinate—Diarrhoea—Doxorubicin—hematologic cancer	0.000156	0.00016	CcSEcCtD
Dimenhydrinate—Rash—Epirubicin—hematologic cancer	0.000155	0.000159	CcSEcCtD
Dimenhydrinate—Dermatitis—Epirubicin—hematologic cancer	0.000155	0.000159	CcSEcCtD
Dimenhydrinate—Headache—Epirubicin—hematologic cancer	0.000154	0.000158	CcSEcCtD
Dimenhydrinate—Dizziness—Doxorubicin—hematologic cancer	0.00015	0.000155	CcSEcCtD
Dimenhydrinate—Nausea—Epirubicin—hematologic cancer	0.000146	0.00015	CcSEcCtD
Dimenhydrinate—Vomiting—Doxorubicin—hematologic cancer	0.000145	0.000149	CcSEcCtD
Dimenhydrinate—Rash—Doxorubicin—hematologic cancer	0.000143	0.000147	CcSEcCtD
Dimenhydrinate—Dermatitis—Doxorubicin—hematologic cancer	0.000143	0.000147	CcSEcCtD
Dimenhydrinate—Headache—Doxorubicin—hematologic cancer	0.000142	0.000146	CcSEcCtD
Dimenhydrinate—Nausea—Doxorubicin—hematologic cancer	0.000135	0.000139	CcSEcCtD
Dimenhydrinate—CHRM2—GPCR downstream signaling—JAK1—hematologic cancer	1.87e-05	0.00068	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PRKCG—hematologic cancer	1.87e-05	0.00068	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—STAT5B—hematologic cancer	1.87e-05	0.000679	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—RAC2—hematologic cancer	1.87e-05	0.000679	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—DKK1—hematologic cancer	1.85e-05	0.000674	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—STAT5B—hematologic cancer	1.84e-05	0.000668	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ADCY7—hematologic cancer	1.81e-05	0.000659	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—CSF2—hematologic cancer	1.79e-05	0.000651	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ADCY7—hematologic cancer	1.78e-05	0.000649	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—IL2RA—hematologic cancer	1.78e-05	0.000646	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—XIAP—hematologic cancer	1.76e-05	0.000642	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—CSF2—hematologic cancer	1.76e-05	0.00064	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—IL2RA—hematologic cancer	1.75e-05	0.000635	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—XIAP—hematologic cancer	1.74e-05	0.000631	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—JAK1—hematologic cancer	1.73e-05	0.000628	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PRKCG—hematologic cancer	1.73e-05	0.000628	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SMARCA4—hematologic cancer	1.72e-05	0.000625	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SH2B3—hematologic cancer	1.72e-05	0.000625	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—GZMB—hematologic cancer	1.71e-05	0.000621	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—JAK1—hematologic cancer	1.7e-05	0.000618	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PRKCG—hematologic cancer	1.7e-05	0.000618	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SH2B3—hematologic cancer	1.69e-05	0.000615	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SMARCA4—hematologic cancer	1.69e-05	0.000615	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—GZMB—hematologic cancer	1.68e-05	0.000611	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CTNNA1—hematologic cancer	1.67e-05	0.000607	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—EIF4EBP1—hematologic cancer	1.66e-05	0.000603	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CCL3—hematologic cancer	1.66e-05	0.000603	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HSPB1—hematologic cancer	1.66e-05	0.000603	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CTNNA1—hematologic cancer	1.64e-05	0.000597	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PTHLH—hematologic cancer	1.64e-05	0.000596	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SDC1—hematologic cancer	1.64e-05	0.000596	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—EIF4EBP1—hematologic cancer	1.63e-05	0.000594	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HSPB1—hematologic cancer	1.63e-05	0.000594	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CCL3—hematologic cancer	1.63e-05	0.000594	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PTHLH—hematologic cancer	1.61e-05	0.000587	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SDC1—hematologic cancer	1.61e-05	0.000587	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—IL2RA—hematologic cancer	1.61e-05	0.000586	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PTGER4—hematologic cancer	1.6e-05	0.000581	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—LCK—hematologic cancer	1.59e-05	0.000578	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—IL2RA—hematologic cancer	1.59e-05	0.000577	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PTGER4—hematologic cancer	1.57e-05	0.000571	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—LCK—hematologic cancer	1.56e-05	0.000568	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—H3F3A—hematologic cancer	1.56e-05	0.000566	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—H3F3A—hematologic cancer	1.53e-05	0.000557	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PRKCZ—hematologic cancer	1.51e-05	0.00055	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PRKCZ—hematologic cancer	1.49e-05	0.000542	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—PIK3CG—hematologic cancer	1.48e-05	0.000538	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PARP1—hematologic cancer	1.46e-05	0.000532	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PIK3CG—hematologic cancer	1.46e-05	0.000529	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PARP1—hematologic cancer	1.44e-05	0.000523	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—FBXW7—hematologic cancer	1.44e-05	0.000523	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—FBXW7—hematologic cancer	1.41e-05	0.000515	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HDAC2—hematologic cancer	1.41e-05	0.000513	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CXCR4—hematologic cancer	1.41e-05	0.000513	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HDAC2—hematologic cancer	1.39e-05	0.000505	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CXCR4—hematologic cancer	1.39e-05	0.000505	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CBL—hematologic cancer	1.37e-05	0.0005	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—IL3—hematologic cancer	1.36e-05	0.000495	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CBL—hematologic cancer	1.35e-05	0.000492	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PIK3CG—hematologic cancer	1.34e-05	0.000489	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—IL3—hematologic cancer	1.34e-05	0.000487	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PTPN1—hematologic cancer	1.34e-05	0.000486	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PIK3CG—hematologic cancer	1.32e-05	0.000481	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PTPN11—hematologic cancer	1.32e-05	0.00048	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PTPN1—hematologic cancer	1.31e-05	0.000478	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—RASGRP1—hematologic cancer	1.31e-05	0.000478	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HSP90AA1—hematologic cancer	1.31e-05	0.000477	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SYK—hematologic cancer	1.31e-05	0.000477	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—PIK3CD—hematologic cancer	1.3e-05	0.000473	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PTPN11—hematologic cancer	1.3e-05	0.000472	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—RASGRP1—hematologic cancer	1.29e-05	0.000471	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HSP90AA1—hematologic cancer	1.29e-05	0.000469	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SYK—hematologic cancer	1.29e-05	0.000469	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PIK3CD—hematologic cancer	1.28e-05	0.000465	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—CREB1—hematologic cancer	1.28e-05	0.000465	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—STAT1—hematologic cancer	1.26e-05	0.00046	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—CREB1—hematologic cancer	1.26e-05	0.000458	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—CCL2—hematologic cancer	1.25e-05	0.000455	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—IL6R—hematologic cancer	1.25e-05	0.000454	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—STAT1—hematologic cancer	1.24e-05	0.000452	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—CCL2—hematologic cancer	1.23e-05	0.000448	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—PIK3R1—hematologic cancer	1.23e-05	0.000447	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—IL6R—hematologic cancer	1.23e-05	0.000446	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PIK3R1—hematologic cancer	1.21e-05	0.000439	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—JAK2—hematologic cancer	1.19e-05	0.000434	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—MAP2K1—hematologic cancer	1.19e-05	0.000432	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—GRB2—hematologic cancer	1.18e-05	0.00043	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PIK3CD—hematologic cancer	1.18e-05	0.000429	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PDGFA—hematologic cancer	1.18e-05	0.000429	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—JAK2—hematologic cancer	1.17e-05	0.000427	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—MAP2K1—hematologic cancer	1.17e-05	0.000425	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—GRB2—hematologic cancer	1.16e-05	0.000423	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—KITLG—hematologic cancer	1.16e-05	0.000423	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PIK3CD—hematologic cancer	1.16e-05	0.000423	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PDGFA—hematologic cancer	1.16e-05	0.000422	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—KITLG—hematologic cancer	1.14e-05	0.000416	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—STAT5A—hematologic cancer	1.14e-05	0.000413	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—PIK3CB—hematologic cancer	1.13e-05	0.000412	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CDKN2B—hematologic cancer	1.13e-05	0.00041	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—STAT5A—hematologic cancer	1.12e-05	0.000407	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PIK3CB—hematologic cancer	1.11e-05	0.000406	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PIK3R1—hematologic cancer	1.11e-05	0.000406	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CDKN2B—hematologic cancer	1.11e-05	0.000403	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PIK3R1—hematologic cancer	1.1e-05	0.000399	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CD86—hematologic cancer	1.09e-05	0.000396	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—JAK2—hematologic cancer	1.08e-05	0.000394	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HES1—hematologic cancer	1.07e-05	0.000391	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CD86—hematologic cancer	1.07e-05	0.00039	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NCOR1—hematologic cancer	1.07e-05	0.000389	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—JAK2—hematologic cancer	1.07e-05	0.000388	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HES1—hematologic cancer	1.06e-05	0.000385	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CSF2—hematologic cancer	1.06e-05	0.000384	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—FGF1—hematologic cancer	1.06e-05	0.000384	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NCOR1—hematologic cancer	1.05e-05	0.000382	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—FOXO1—hematologic cancer	1.04e-05	0.000379	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—IL2—hematologic cancer	1.04e-05	0.000379	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—FGF1—hematologic cancer	1.04e-05	0.000378	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CSF2—hematologic cancer	1.04e-05	0.000378	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PDGFRB—hematologic cancer	1.04e-05	0.000378	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PIK3CB—hematologic cancer	1.03e-05	0.000374	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—FOXO1—hematologic cancer	1.02e-05	0.000373	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—IL2—hematologic cancer	1.02e-05	0.000373	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PDGFRA—hematologic cancer	1.02e-05	0.000372	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PDGFRB—hematologic cancer	1.02e-05	0.000372	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—JAK1—hematologic cancer	1.02e-05	0.000371	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PRKCG—hematologic cancer	1.02e-05	0.000371	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PIK3CB—hematologic cancer	1.01e-05	0.000368	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PDGFRA—hematologic cancer	1.01e-05	0.000366	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PRKCG—hematologic cancer	1e-05	0.000365	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—JAK1—hematologic cancer	1e-05	0.000365	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—IL2RA—hematologic cancer	9.52e-06	0.000346	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—IL2—hematologic cancer	9.45e-06	0.000344	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—TERT—hematologic cancer	9.42e-06	0.000343	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—IL2RA—hematologic cancer	9.37e-06	0.000341	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—IL2—hematologic cancer	9.3e-06	0.000338	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—TERT—hematologic cancer	9.26e-06	0.000337	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PDGFB—hematologic cancer	9.19e-06	0.000334	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PDGFB—hematologic cancer	9.04e-06	0.000329	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—TSC2—hematologic cancer	8.98e-06	0.000327	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—TSC2—hematologic cancer	8.84e-06	0.000322	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—FGFR3—hematologic cancer	8.64e-06	0.000314	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MAPK14—hematologic cancer	8.55e-06	0.000311	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—FGFR3—hematologic cancer	8.5e-06	0.000309	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MAPK14—hematologic cancer	8.42e-06	0.000306	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ESR1—hematologic cancer	8.39e-06	0.000305	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—FN1—hematologic cancer	8.29e-06	0.000302	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ESR1—hematologic cancer	8.26e-06	0.0003	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—BAD—hematologic cancer	8.19e-06	0.000298	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NFKBIA—hematologic cancer	8.19e-06	0.000298	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—FN1—hematologic cancer	8.16e-06	0.000297	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NOTCH1—hematologic cancer	8.11e-06	0.000295	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—BAD—hematologic cancer	8.06e-06	0.000293	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NFKBIA—hematologic cancer	8.06e-06	0.000293	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NOTCH1—hematologic cancer	7.98e-06	0.00029	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CD80—hematologic cancer	7.95e-06	0.000289	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PIK3CG—hematologic cancer	7.93e-06	0.000289	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—KIT—hematologic cancer	7.93e-06	0.000289	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—NRAS—hematologic cancer	7.93e-06	0.000289	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CD80—hematologic cancer	7.82e-06	0.000285	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PIK3CG—hematologic cancer	7.81e-06	0.000284	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—KIT—hematologic cancer	7.81e-06	0.000284	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—NRAS—hematologic cancer	7.81e-06	0.000284	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PTPN11—hematologic cancer	7.79e-06	0.000284	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PTPN11—hematologic cancer	7.67e-06	0.000279	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—MAPK3—hematologic cancer	7.6e-06	0.000276	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CREB1—hematologic cancer	7.55e-06	0.000275	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—MAPK3—hematologic cancer	7.48e-06	0.000272	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—BRAF—hematologic cancer	7.46e-06	0.000271	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CREB1—hematologic cancer	7.43e-06	0.00027	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CCL2—hematologic cancer	7.39e-06	0.000269	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—IL6R—hematologic cancer	7.37e-06	0.000268	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CREBBP—hematologic cancer	7.36e-06	0.000268	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—BRAF—hematologic cancer	7.34e-06	0.000267	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CCL2—hematologic cancer	7.27e-06	0.000264	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—IL6R—hematologic cancer	7.25e-06	0.000264	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CREBBP—hematologic cancer	7.24e-06	0.000263	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MAP2K1—hematologic cancer	7.02e-06	0.000255	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PIK3CD—hematologic cancer	6.97e-06	0.000254	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—PIK3CA—hematologic cancer	6.91e-06	0.000251	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MAP2K1—hematologic cancer	6.91e-06	0.000251	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PIK3CD—hematologic cancer	6.86e-06	0.00025	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—KRAS—hematologic cancer	6.83e-06	0.000248	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PIK3CA—hematologic cancer	6.8e-06	0.000247	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—KRAS—hematologic cancer	6.72e-06	0.000244	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—FGF2—hematologic cancer	6.68e-06	0.000243	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PIK3R1—hematologic cancer	6.59e-06	0.00024	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—FGF2—hematologic cancer	6.57e-06	0.000239	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PIK3R1—hematologic cancer	6.48e-06	0.000236	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—JAK2—hematologic cancer	6.4e-06	0.000233	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—JAK2—hematologic cancer	6.3e-06	0.000229	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PIK3CA—hematologic cancer	6.27e-06	0.000228	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MDM2—hematologic cancer	6.25e-06	0.000227	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PIK3CA—hematologic cancer	6.17e-06	0.000225	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MDM2—hematologic cancer	6.15e-06	0.000224	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MTOR—hematologic cancer	6.08e-06	0.000221	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PIK3CB—hematologic cancer	6.08e-06	0.000221	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MTOR—hematologic cancer	5.98e-06	0.000218	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PIK3CB—hematologic cancer	5.98e-06	0.000218	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—HRAS—hematologic cancer	5.8e-06	0.000211	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—HRAS—hematologic cancer	5.71e-06	0.000208	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CDKN1B—hematologic cancer	5.7e-06	0.000208	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—AKT1—hematologic cancer	5.64e-06	0.000205	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CDKN1B—hematologic cancer	5.61e-06	0.000204	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CASP3—hematologic cancer	5.59e-06	0.000203	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—IL2—hematologic cancer	5.58e-06	0.000203	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—IL6—hematologic cancer	5.55e-06	0.000202	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—AKT1—hematologic cancer	5.55e-06	0.000202	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CASP3—hematologic cancer	5.5e-06	0.0002	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—IL2—hematologic cancer	5.49e-06	0.0002	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—IL6—hematologic cancer	5.47e-06	0.000199	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CCND1—hematologic cancer	5.44e-06	0.000198	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—JUN—hematologic cancer	5.43e-06	0.000198	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CCND1—hematologic cancer	5.35e-06	0.000195	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—JUN—hematologic cancer	5.34e-06	0.000194	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CDKN1A—hematologic cancer	5.26e-06	0.000192	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PTEN—hematologic cancer	5.25e-06	0.000191	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	5.18e-06	0.000188	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PTEN—hematologic cancer	5.17e-06	0.000188	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MAPK8—hematologic cancer	5.14e-06	0.000187	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—AKT1—hematologic cancer	5.12e-06	0.000186	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	5.06e-06	0.000184	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	5.04e-06	0.000183	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—EP300—hematologic cancer	5.01e-06	0.000182	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—EP300—hematologic cancer	4.93e-06	0.000179	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SRC—hematologic cancer	4.87e-06	0.000177	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SRC—hematologic cancer	4.79e-06	0.000174	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—VEGFA—hematologic cancer	4.74e-06	0.000173	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—STAT3—hematologic cancer	4.7e-06	0.000171	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NRAS—hematologic cancer	4.69e-06	0.00017	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	4.67e-06	0.00017	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—STAT3—hematologic cancer	4.62e-06	0.000168	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NRAS—hematologic cancer	4.61e-06	0.000168	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MAPK3—hematologic cancer	4.49e-06	0.000163	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	4.42e-06	0.000161	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MYC—hematologic cancer	4.37e-06	0.000159	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—TGFB1—hematologic cancer	4.35e-06	0.000158	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MYC—hematologic cancer	4.3e-06	0.000156	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	4.28e-06	0.000156	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—KRAS—hematologic cancer	4.03e-06	0.000147	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—KRAS—hematologic cancer	3.97e-06	0.000144	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	3.71e-06	0.000135	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	3.65e-06	0.000133	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—TP53—hematologic cancer	3.58e-06	0.00013	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—TP53—hematologic cancer	3.53e-06	0.000128	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HRAS—hematologic cancer	3.43e-06	0.000125	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HRAS—hematologic cancer	3.37e-06	0.000123	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—IL6—hematologic cancer	3.28e-06	0.000119	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—IL6—hematologic cancer	3.23e-06	0.000117	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—AKT1—hematologic cancer	3.03e-06	0.00011	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—AKT1—hematologic cancer	2.98e-06	0.000108	CbGpPWpGaD
